tradingkey.logo
tradingkey.logo

AbbVie in talks to acquire Gilgamesh Pharmaceuticals

ReutersJul 30, 2025 10:23 PM

- Drugmaker AbbVie ABBV.N is in talks to acquire privately-held mental health therapeutics company Gilgamesh Pharmaceuticals in a deal worth about $1 billion, Bloomberg News reported on Wednesday, citing people familiar with the matter.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI